ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Oppenheimer Holdings Inc

Oppenheimer Holdings Inc (OPY)

72.38
1.04
(1.46%)
At close: January 29 3:00PM
72.38
0.00
( 0.00% )
After Hours: 4:30PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
72.38
Bid
-
Ask
-
Volume
16,445
70.84 Day's Range 73.07
36.93 52 Week Range 72.88
Market Cap
Previous Close
71.34
Open
71.85
Last Trade
2344
@
72.38
Last Trade Time
17:30:00
Financial Volume
US$ 1,182,165
VWAP
71.886
Average Volume (3m)
29,352
Shares Outstanding
10,331,401
Dividend Yield
0.99%
PE Ratio
24.79
Earnings Per Share (EPS)
2.92
Revenue
1.16B
Net Profit
30.18M

About Oppenheimer Holdings Inc

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset managem... Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has three segments: private client, asset management, and capital markets. The private client segment, including full-service brokerage, wealth planning, and margin lending, contributes over half of total revenue. The company generates the majority of revenue from the Americas, with the rest from Europe, the Middle East, and Asia. Show more

Sector
Finance Services
Industry
Investment Advice
Website
Headquarters
New York, New York, USA
Founded
1992
Oppenheimer Holdings Inc is listed in the Finance Services sector of the New York Stock Exchange with ticker OPY. The last closing price for Oppenheimer was US$71.34. Over the last year, Oppenheimer shares have traded in a share price range of US$ 36.93 to US$ 72.88.

Oppenheimer currently has 10,331,401 shares outstanding. The market capitalization of Oppenheimer is US$737.04 million. Oppenheimer has a price to earnings ratio (PE ratio) of 24.79.

OPY Latest News

Oppenheimer Announces Expansion of Emerging Markets Desk

Oppenheimer Announces Expansion of Emerging Markets Desk PR Newswire NEW YORK, Dec. 17, 2024 Strategic Recruitments of Persio 'Tony' Perez, Michael Chatman and Bill Dolan as Managing Directors...

Craig Schneider Joins Oppenheimer As Regional Director of Michigan

Craig Schneider Joins Oppenheimer As Regional Director of Michigan PR Newswire NEW YORK, Dec. 4, 2024 Wealth Management Veteran Brings Over 25 Years of Industry Experience Appointment Builds on...

Pontera and Oppenheimer partner to empower holistic wealth management that incorporates clients' 401(k)s

Pontera and Oppenheimer partner to empower holistic wealth management that incorporates clients' 401(k)s PR Newswire NEW YORK, Nov. 14, 2024 Top 10 U.S. broker-dealer will leverage Pontera's...

Oppenheimer Concludes 20th Annual Professionals Alliance Group (PAG) Conference

Oppenheimer Concludes 20th Annual Professionals Alliance Group (PAG) Conference PR Newswire NEW YORK, Nov. 13, 2024 Event Gathered CPAs and Other Trusted Industry Professionals with Select Group...

Oppenheimer Holdings Inc. Reports Third Quarter 2024 Earnings

Oppenheimer Holdings Inc. Reports Third Quarter 2024 Earnings PR Newswire NEW YORK, Oct. 25, 2024 NEW YORK, Oct. 25, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the...

Oppenheimer Hires Christian Baetz As Managing Director, Consumer Investment Banking

Oppenheimer Hires Christian Baetz As Managing Director, Consumer Investment Banking PR Newswire NEW YORK, Oct. 15, 2024 NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.50.69560378408571.8872.8869.872048571.22120506CS
47.611.732016054364.7872.8861.762327367.01977511CS
1211.9719.814600231760.4172.8858.892935263.85382569CS
2618.8735.264436553953.5172.8847.393203956.24840823CS
5234.4991.026656109837.8972.8836.933520649.60302524CS
15631.376.192794547241.0872.8828.266199040.45823916CS
26046.32177.74366845726.0672.8814.21017938537.6129011CS

OPY - Frequently Asked Questions (FAQ)

What is the current Oppenheimer share price?
The current share price of Oppenheimer is US$ 72.38
How many Oppenheimer shares are in issue?
Oppenheimer has 10,331,401 shares in issue
What is the market cap of Oppenheimer?
The market capitalisation of Oppenheimer is USD 737.04M
What is the 1 year trading range for Oppenheimer share price?
Oppenheimer has traded in the range of US$ 36.93 to US$ 72.88 during the past year
What is the PE ratio of Oppenheimer?
The price to earnings ratio of Oppenheimer is 24.79
What is the cash to sales ratio of Oppenheimer?
The cash to sales ratio of Oppenheimer is 0.65
What is the reporting currency for Oppenheimer?
Oppenheimer reports financial results in USD
What is the latest annual turnover for Oppenheimer?
The latest annual turnover of Oppenheimer is USD 1.16B
What is the latest annual profit for Oppenheimer?
The latest annual profit of Oppenheimer is USD 30.18M
What is the registered address of Oppenheimer?
The registered address for Oppenheimer is 85 BROAD STREET, NEW YORK, NEW YORK, 10004
What is the Oppenheimer website address?
The website address for Oppenheimer is www.opco.com
Which industry sector does Oppenheimer operate in?
Oppenheimer operates in the INVESTMENT ADVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CLSCelestica Inc
US$ 114.00
(13.44%)
737.41k
IBMInternational Business Machines Corp
US$ 248.59
(8.73%)
1.04M
CALXCalix Inc
US$ 40.00
(8.49%)
31.52k
LVSLas Vegas Sands Corp
US$ 46.53
(7.14%)
544.06k
ENFYEnlightify Inc
US$ 1.39
(6.92%)
1.73k
WHRWhirlpool Corp
US$ 112.69
(-13.17%)
113.91k
CLBCore Laboratories Inc
US$ 17.01
(-8.25%)
13.42k
NOWServiceNow Inc
US$ 1,050.00
(-8.19%)
279.25k
BFLYButterfly Network Inc
US$ 3.24
(-7.69%)
340.43k
LEVILevi Strauss and Co
US$ 16.79
(-7.19%)
303.78k
LUMNLumen Technologies Inc
US$ 5.00
(-0.20%)
11.38M
CCLCarnival Corp
US$ 27.94
(0.11%)
2.11M
PCGPG&E Corporation
US$ 15.84
(0.32%)
1.57M
WOLFWolfspeed Inc
US$ 6.03
(0.50%)
1.29M
VZVerizon Communications Inc
US$ 40.29
(0.02%)
1.13M

Discussion

View Full Feed
Backstabbed Backstabbed 5 minutes ago
25,000 shares x $0.20 = $5,000 USD
ZHUD
newmedman newmedman 5 minutes ago
Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o
MartinLutherKing MartinLutherKing 5 minutes ago
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?
RNAZ
valuemind valuemind 5 minutes ago
2025-2027 will be TSLA years!
TSLA
jondoeuk jondoeuk 6 minutes ago
The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.
FATE
MartinLutherKing MartinLutherKing 7 minutes ago
FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl
RNAZ
Backstabbed Backstabbed 7 minutes ago
50,000 shares x $0.20 = $10,000 USD
ZHUD
Backstabbed Backstabbed 8 minutes ago
100,000 shares x $0.20 = $20,000 USD
ZHUD
Backstabbed Backstabbed 8 minutes ago
250,000 shares x $0.20 = $50,000 USD
ZHUD
ChartTRACKER ChartTRACKER 8 minutes ago
$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.
ADTX
Backstabbed Backstabbed 9 minutes ago
500,000 shares x $0.20 = $100,000
ZHUD
Techroemancer Techroemancer 9 minutes ago
Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an
ASII
MartinLutherKing MartinLutherKing 9 minutes ago
TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di
RNAZ
zab zab 9 minutes ago
Trump's pandemic killed 1.3 million Americans,  you must be so happy with his choice to downplay it.
Backstabbed Backstabbed 9 minutes ago
1,000,000 shares x $0.20 = $200,000 USD
ZHUD
Backstabbed Backstabbed 10 minutes ago
Cohen said $0.20 by May 2025! $ZHUD
ZHUD
stealofadeal stealofadeal 10 minutes ago
$KRTL Another good day today. Thin share structure and going to move fast.
KRTL
bb8675309 bb8675309 10 minutes ago
Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market
AVXL
Whalatane Whalatane 10 minutes ago
Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi
UNCY
Ex-brokerBry Ex-brokerBry 10 minutes ago
Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y
UMAV
jondoeuk jondoeuk 10 minutes ago
We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr
FATE
nowwhat2 nowwhat2 11 minutes ago
What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg
valuemind valuemind 11 minutes ago
NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.
FSLR NXT

Your Recent History

Delayed Upgrade Clock